Role of novel targeted therapies in the clinic
2005
Role of Novel Targeted Therapies in Cancer Treatment
publication
Evidence: moderate
Author Information
Author(s): Herbst R S
Primary Institution: The University of Texas MD Anderson Cancer Center
Hypothesis
What approach should be used for targeted therapies in cancer treatment?
Conclusion
Novel targeted therapies show promise in improving cancer treatment outcomes, but their clinical evaluation is still in early stages.
Supporting Evidence
- Molecular-targeted agents have shown potential in inhibiting tumor growth.
- Bevacizumab has demonstrated a survival benefit when combined with chemotherapy.
- Targeted therapies may have lower toxicity compared to conventional chemotherapy.
Takeaway
Doctors are finding new ways to treat cancer by using special medicines that target the cancer cells directly, which might help people feel better with fewer side effects.
Methodology
The manuscript reviews current understanding and clinical applications of molecular-targeted therapies.
Limitations
Clinical experience with targeted therapies is still limited, and their long-term effects need further evaluation.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website